Literature DB >> 11264467

Lysophospholipid receptors.

N Fukushima1, I Ishii, J J Contos, J A Weiner, J Chun.   

Abstract

Lysophospholipids (LPs), including lysophosphatidic acid and sphingosine 1-phosphate, produce many cellular effects. However, the prolonged absence of any cloned and identified LP receptor has left open the question of how these lipids actually bring about these effects. The cloning and functional identification of the first LP receptor, lp(A1)/vzg-1, has led rapidly to the identification and classification of multiple orphan receptors/expression sequence tags known by many names (e.g. edg, mrec1.3, gpcr26, H218, AGR16, nrg-1) as members of a common cognate G protein-coupled receptor family. We review features of the LP receptor family, including molecular characteristics, genomics, signaling properties, and gene expression. A major question for which only partial answers are available concerns the biological significance of receptor-mediated LP signaling. Recent studies that demonstrate the role of receptor-mediated LP signaling in the nervous system, cardiovascular system, and other organ systems indicate the importance of this signaling in development, function, and pathophysiology and portend an exciting time ahead for this growing field.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264467     DOI: 10.1146/annurev.pharmtox.41.1.507

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  81 in total

1.  Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist.

Authors:  Hugh Rosen; Christopher Alfonso; Charles D Surh; Michael G McHeyzer-Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

Review 2.  [Oral fingolimod in multiple sclerosis: therapeutic modulation of the sphingosine-1-phosphate system].

Authors:  O Aktas; J Ingwersen; B Kieseier; P Küry; R Hohlfeld; H-P Hartung
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

3.  Direct voltage control of endogenous lysophosphatidic acid G-protein-coupled receptors in Xenopus oocytes.

Authors:  Juan Martinez-Pinna; Iman S Gurung; Martyn P Mahaut-Smith; Andrés Morales
Journal:  J Physiol       Date:  2010-03-29       Impact factor: 5.182

Review 4.  A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).

Authors:  Jerold Chun; Volker Brinkmann
Journal:  Discov Med       Date:  2011-09       Impact factor: 2.970

Review 5.  International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.

Authors:  Jerold Chun; Timothy Hla; Kevin R Lynch; Sarah Spiegel; Wouter H Moolenaar
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

6.  The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.

Authors:  Songbai Lin; Sei-Jung Lee; Hyunsuk Shim; Jerold Chun; C Chris Yun
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-19       Impact factor: 4.052

Review 7.  Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs.

Authors:  Mitchell K P Lai; Wee Siong Chew; Federico Torta; Angad Rao; Greg L Harris; Jerold Chun; Deron R Herr
Journal:  Neuromolecular Med       Date:  2016-07-08       Impact factor: 3.843

Review 8.  Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.

Authors:  Mu-En Lin; Deron R Herr; Jerold Chun
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-03-04       Impact factor: 3.072

9.  T cell chemotaxis to lysophosphatidylcholine through the G2A receptor.

Authors:  Caius G Radu; Li V Yang; Mireille Riedinger; Matthew Au; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-17       Impact factor: 11.205

10.  Formation of transient non-protein calcium pores by lysophospholipids in S49 Lymphoma cells.

Authors:  H A Wilson-Ashworth; A M Judd; R M Law; B D Freestone; S Taylor; M K Mizukawa; K R Cromar; S Sudweeks; J D Bell
Journal:  J Membr Biol       Date:  2004-07-01       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.